Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
81.6M
-
Shares change
-
-1.5M
-
Total reported value, excl. options
-
$1.94B
-
Value change
-
-$37.9M
-
Put/Call ratio
-
1.08
-
Number of buys
-
83
-
Number of sells
-
-123
-
Price
-
$23.79
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2021
256 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q1 2021.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.6M shares
of 106M outstanding shares and own 77.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.2M shares), VANGUARD GROUP INC (12.4M shares), RENAISSANCE TECHNOLOGIES LLC (8.77M shares), INGALLS & SNYDER LLC (6.95M shares), FEDERATED HERMES, INC. (5.08M shares), STATE STREET CORP (3.22M shares), DIMENSIONAL FUND ADVISORS LP (2.61M shares), GEODE CAPITAL MANAGEMENT, LLC (1.77M shares), Parallel Advisors, LLC (1.56M shares), and NORTHERN TRUST CORP (1.24M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.